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Peptide-based hydrogels are an important class of biomaterials with a wide range of applications, which include 
among others drug delivery, tissue engineering, in vivo imaging and template materials. Particularly, self-assembled 
biocompatible peptide-based hydrogels have been successfully synthesized and evaluated as nanocarriers for 
antitumor drugs [1,2].  
The incorporation of magnetic nanoparticles in these biocompatible nanosystems, forming nanomagnetogels, will 
allow their concentration in the therapeutic sites by magnetic forces, allowing the guided transport of anticancer 
drugs, most of them toxic and with systemic side effects. Therefore, a promising application of these 
nanomagnetogels in cancer therapy is anticipated, through synergystic magnetically-guided drug delivery and 
hyperthermia [3,4].  
In this work, superparamagnetic manganese ferrite (MnFe2O4) nanoparticles (Fig. 1), synthesized as previously 
described [5], were successfully incorporated in self-assembled peptide-derived hydrogels. The new magnetogels 
were tested as nanocarriers for two fluorescent drugs, curcumin (an anticancer and neuroprotective drug) and a new 
antitumor thienopyridine derivative [6]. Fluorescence-based techniques (fluorescence emission, FRET and 
fluorescence anisotropy) were used to assess incorporation of these drugs in the magnetogels and their transport 
towards models of biological membranes. For that purpose, small unilamelar vesicles (SUVs) of lecithin/cholesterol 
7:3 were used as membrane models. Delivery of drugs towards SUVs was monitored through FRET assays from the 
fluorescent drug (acting as the energy donor) and the dye Nile Red (energy acceptor) included in SUVs (Fig. 2). It 
can be observed that the drug moves to the model membranes upon interaction of the drug-loaded magnetogels 
with SUVs. These results are promising for the use of these magnetogels in dual cancer therapy, by combination of 
chemotherapy and magnetic hyperthermia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: TEM image of manganese 
ferrite nanoparticles prepared by 
coprecipitation method. 
 
 
Fig. 2: Fluorescence spectra of curcumin-loaded magnetogel, model 
membranes (SUVs) with the dye Nile Red, and interaction showing the 
release of curcumin into SUVs (by FRET, exciting only curcumin). 
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